Connect with us


Leva Clinic set to expand to reach more chronic pain patients

Leva Clinic prescribes medical cannabis among a range of other chronic pain treatments.



Leva Clinic set to expand to reach more chronic pain patients

The online pain clinic and prescriber of cannabis medicines is set for expansion to help tackle the ‘silent epidemic’ affecting millions of patients across the country.

Leva Clinic, which prescribes medical cannabis to patients living with chronic pain, is set to expand its reach following investment from two major industry players. 

The clinic has secured £3 million of funding from Óskare Capital and the founder of Weedmaps, Justin Hartfield, to scale the delivery of its digital first solutions which are aimed at improving the health and wellbeing of chronic pain sufferers. 

Dubbed the ‘silent epidemic’, studies suggest chronic pain could affect more than two fifths of the UK population, meaning that 28 million adults are living with pain that has lasted for three months or longer. 

Established in 2019, Leva Clinic is the UK’s first online clinic for chronic pain, delivering a range of services to help patients manage their condition. 

It is a member of Project Twenty21, the UK observational study gathering evidence on the efficacy of cannabis-based medicines. 

As the producer of Satoline, it is also one of three suppliers participating in the ‘I Am Billy’ Foundation programme, which is helping to subsidise the cost of products for children with severe epilepsy, who are undergoing assessment by the Refractory Epilepsy Specialist Clinical Advisory Service (RESCAS).

Leva’s services are accessible through the Boots Health Hub and the clinic also has developed partnerships with several NHS trusts.

Co-founder and CEO Eric Bystrom said the investment would be used to help more patients across the UK access its services. 

“Leva’s unique patient centric platform is delivering for our patients and with this investment we intend to further increase our reach across the UK and continue to build our offering through digital access,” he commented.

“Justin’s experience in developing digital offerings coupled with Oskare’s life sciences expertise make them the perfect partners for this next stage of our journey.” 

Óskare Capital is a European medical and pharmaceutical cannabis fund.

Oliver Lamb, co-founder and investment manager at Óskare Capital said: “We are excited about our investment in Leva and their much needed pain management platform.

“One of the key issues that Óskare Capital seeks to address in the medical cannabis market is patient access, and Leva are breaking down the barriers for those patients most in need. Having been in discussions with the Leva team for over a year, we have been continually impressed by their vision and dedication.” 

Dr John Rogers, neurologist and co-founder of Óskare, will be joining Leva’s board, along with Dr Arun Bhaskar, a consultant in pain medicine and president of the British Pain Society, who will join as an independent director. 

“We have been impressed by Leva’s approach to patient care, also affirmed by their NHS contracts and recent CQC report,” commented Rogers.

“Leva has assembled a highly experienced team of pain management experts, and we are excited to help Leva make these patient services available across the UK.” 


Home » Industry » Leva Clinic set to expand to reach more chronic pain patients

Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK’s leading title covering medical cannabis and CBD, and sister titles, Cannabis Wealth and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA’s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email / Follow us on Twitter: @CannabisHNews / Instagram: @cannabishealthmag


Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2023 PP Intelligence Ltd.